Home » Topics » Disease categories and therapies » Infection

Infection
RSS

WHO teams up with Japanese government and industry to identify antimalarial drugs

Nov. 15, 1999

Potent, broad-spectrum, orally bioavailable carbapenems designed by Sankyo

Nov. 12, 1999

Bristol-Myers Squibb begins phase II testing of inlicensed quinolone

Nov. 12, 1999

New data reported for Tamiflu as influenza treatment and prophylaxis

Nov. 10, 1999

Inhibitex enters collaboration with ZLB for S. aureus antiinfective agents

Nov. 8, 1999

Potential interaction between S-4661 and valproic acid

Nov. 8, 1999

Antiviral agents discovered at U. of Michigan

Nov. 8, 1999

Glaxo Wellcome files for approval of new Relenza indications: influenza prophylaxis, pediatric use

Nov. 8, 1999

Large clinical trial to evaluate AG-7088 nasal spray as a common cold remedy commences

Nov. 5, 1999

Novel inhibitors of multidrug transporter mediating fluoroquinolone efflux

Nov. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...